Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!

>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur

Summary:

FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled

Summary:

Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Responds to Release of GAO Drug Shortage Report

Friday, December 16, 2011

Recently, the Government Accountability Office (GAO) released a long-awaited report on the crisis of drug shortages.  The report is in response to continuing problems that anesthesiologists and other physicians face as they confront an unprecedented number of drug shortages.

ASA President Jerry Cohen, M.D. offered the following remarks about the report’s release:

“ASA was pleased by the release of the GAO Drug Shortages report and appreciated the opportunity to participate as an expert resource in the production of the report. As anesthesiologists continue to confront unprecedented drug shortages across the country, ASA is proud of our efforts in coordination with members of the Drug Shortage Summit to successfully elevate this critical issue in both Congress and the Administration.  We look forward to thoroughly reviewing the GAO report and its recommendations.”

« Back to Washington Alerts